16 results on '"Hu, Xiaochun"'
Search Results
2. A PDA-DTC/Cu–MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment.
3. A multifunctional SN38-conjugated nanosystem for defeating myelosuppression and diarrhea induced by irinotecan in esophageal cancer.
4. [Ru(phen)2podppz]2+ significantly inhibits glioblastoma growth in vitro and vivo with fewer side-effects than cisplatin.
5. Post-synthesis strategy to integrate porphyrinic metal–organic frameworks with CuS NPs for synergistic enhanced photo-therapy.
6. Integrating in situ formation of nanozymes with mesoporous polydopamine for combined chemo, photothermal and hypoxia-overcoming photodynamic therapy.
7. A redox-activated theranostic nanoplatform: toward glutathione-response imaging guided enhanced-photodynamic therapy.
8. Regulation of multi-factors (tail/loop/link/ions) for G-quadruplex enantioselectivity of Δ- and Λ- [Ru(bpy)2(dppz-idzo)]2+.
9. Regulation of multi-factors (tail/loop/link/ions) for G-quadruplex enantioselectivity of Δ- and Λ- [Ru(bpy)2(dppz-idzo)]2+.
10. Three label-free thrombin aptasensors based on aptamers and [Ru(bpy)2(o-mopip)]2+.
11. Hydrothermal synthesis of nanostructured flower-like Ni(OH)2 particles and their excellent sensing performance towards low concentration HCN gas.
12. Synthesis of nanostructured copper oxide via oxalate precursors and their sensing properties for hydrogen cyanide gas.
13. A PDA-DTC/Cu-MnO 2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment.
14. [Ru(phen) 2 podppz] 2+ significantly inhibits glioblastoma growth in vitro and vivo with fewer side-effects than cisplatin.
15. Regulation of multi-factors (tail/loop/link/ions) for G-quadruplex enantioselectivity of Δ- and Λ- [Ru(bpy) 2 (dppz-idzo)] 2 .
16. Three label-free thrombin aptasensors based on aptamers and [Ru(bpy) 2 (o-mopip)] 2 .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.